Suppr超能文献

在汉族人群中使用遗传风险评分对散发性阿尔茨海默病进行风险预测。

Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population.

作者信息

Xiao Qianyi, Liu Zhi-Jun, Tao Sha, Sun Yi-Min, Jiang Deke, Li Hong-Lei, Chen Haitao, Liu Xu, Lapin Brittany, Wang Chi-Hsiung, Zheng S Lilly, Xu Jianfeng, Wu Zhi-Ying

机构信息

Center for Genomic Translational Medicine and Prevention, School of Public Health, Fudan University, Shanghai, China.

Department of Neurology and Research Center of Neurology in Second Affiliated Hospital, and the Collaborative Innovation Center for Brain Science, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Oncotarget. 2015 Nov 10;6(35):36955-64. doi: 10.18632/oncotarget.6271.

Abstract

More than 30 independent single-nucleotide polymorphisms (SNPs) have been associated with Alzheimer's disease (AD) risk by genome-wide association studies (GWAS) in European. We aimed to confirm these SNPs in Chinese Han and investigate the utility of these genetic markers. We randomly divided 459 sporadic AD (SAD) patients and 751 cognitively normal controls into two sets (discovery and testing). Thirty-three SAD risk-associated SNPs were firstly tested in the discovery set. Significant SNPs were used to calculate genetic risk score (GRS) in the testing set. Predictive performance of GRS was evaluated using the area under the receiver operating characteristic curve (AUC). In the discovery set, 6 SNPs were confirmed (P = 7.87 x 10(-11)~0.048), including rs9349407 in CD2AP, rs11218343 in SORL1, rs17125944 in FERMT2, rs6859 in PVRL2, rs157580 and rs2075650 in TOMM40. The first three SNPs were associated with SAD risk independent of APOE genotypes. GRS based on these three SNPs were significantly associated with SAD risk in the independent testing set (P = 0.002). The AUC for discriminating cases from controls was 0.58 for GRS, 0.60 for APOE, and 0.64 for GRS and APOE. Our data demonstrated that GRS based on AD risk-associated SNPs may supplement APOE for better assessing individual risk for AD in Chinese.

摘要

通过欧洲的全基因组关联研究(GWAS),已有30多个独立的单核苷酸多态性(SNP)与阿尔茨海默病(AD)风险相关。我们旨在在中国汉族人群中验证这些SNP,并研究这些遗传标记的效用。我们将459例散发性AD(SAD)患者和751例认知正常对照随机分为两组(发现组和验证组)。首先在发现组中对33个与SAD风险相关的SNP进行检测。将有显著意义的SNP用于在验证组中计算遗传风险评分(GRS)。使用受试者工作特征曲线下面积(AUC)评估GRS的预测性能。在发现组中,6个SNP得到验证(P = 7.87×10⁻¹¹~0.048),包括CD2AP基因中的rs9349407、SORL1基因中的rs11218343、FERMT2基因中的rs17125944、PVRL2基因中的rs6859、TOMM40基因中的rs157580和rs2075650。前三个SNP与SAD风险相关,且独立于APOE基因型。基于这三个SNP的GRS在独立验证组中与SAD风险显著相关(P = 0.002)。区分病例与对照的AUC,GRS为0.58,APOE为0.60,GRS与APOE联合为0.64。我们的数据表明,基于AD风险相关SNP的GRS可能补充APOE,以便更好地评估中国人患AD的个体风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a92/4741908/0f0daa5dcc16/oncotarget-06-36955-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验